IMPROVED SOLUTIONS FOR PERITONEAL-DIALYSIS - PHYSIOLOGICAL CALCIUM SOLUTIONS, OSMOTIC AGENTS AND BUFFERS

被引:0
|
作者
HUTCHISON, AJ [1 ]
GOKAL, R [1 ]
机构
[1] MANCHESTER ROYAL INFIRM, RENAL DIALYSIS UNIT, OXFORD RD, MANCHESTER M13 9WL, LANCS, ENGLAND
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Theoretical and clinical studies suggest that reduction of PD fluid calcium to 1.25 mmol/liter allows administration of larger doses of calcium carbonate, improves phosphate control and obviates the need for aluminium gels in most CAPD patients, without increasing hypercalcemia or hyperparathyroidism. Hypermagnesemia can also be avoided by reducing PD fluid magnesium concentration to 0.25 mmol/liter. Although glucose is a safe, effective an cheap osmotic agent, it provides a short duration of ultrafiltration, and contributes to significant metabolic abnormalities. Amino acids and glucose polymer are potential alternatives to glucose, and early clinical studies are encouraging. The unphysiological concentration of lactate in PD fluids has been shown to have pathological consequences, and undoubtedly bicarbonate would be a preferable buffer. Manufacturing techniques are being developed to produce such a fluid. A fluid containing bicarbonate and the peptide glycylglycine (30:10 mmol/liter) gives a stable buffer with a pH of 7.35, but has only undergone animal studies so far. Glucose solutions have deleterious effects on the peritoneal membrane, particularly during episodes of severe peritonitis, and the high osmolality is toxic to peritoneal host defense cells. Prompt treatment of peritonitis, early removal of the catheter where necessary, and minimization of glucose exposure, may do much to lengthen the dialysis life of the peritoneum.
引用
收藏
页码:S153 / S159
页数:7
相关论文
共 50 条
  • [1] OSMOTIC AGENTS FOR PERITONEAL-DIALYSIS SOLUTIONS
    WU, G
    [J]. PERITONEAL DIALYSIS BULLETIN, 1982, 2 (04): : 151 - 154
  • [2] OSMOTIC AGENTS FOR PERITONEAL-DIALYSIS
    KHANNA, R
    TWARDOWSKI, ZJ
    OREOPOULOS, DG
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1986, 9 (06): : 387 - 390
  • [3] PERITONEAL-DIALYSIS SOLUTIONS
    OREOPOULOS, DG
    [J]. PERITONEAL DIALYSIS BULLETIN, 1984, 4 (02): : 70 - 71
  • [4] PERITONEAL-DIALYSIS SOLUTIONS
    GAULT, MH
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1973, 108 (03) : 325 - 327
  • [5] OSMOTIC AGENTS AND ULTRAFILTRATION IN PERITONEAL-DIALYSIS
    TWARDOWSKI, ZJ
    KHANNA, R
    NOLPH, KD
    [J]. NEPHRON, 1986, 42 (02): : 93 - 101
  • [6] POLYMERS AS OSMOTIC AGENTS FOR PERITONEAL-DIALYSIS
    TWARDOWSKI, ZJ
    MOORE, HL
    MCGARY, TJ
    POSKUTA, M
    STATHAKIS, C
    HIRSZEL, P
    [J]. PERITONEAL DIALYSIS BULLETIN, 1984, 4 (03): : 125 - 131
  • [7] HES AS AN OSMOTIC AGENT FOR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS SOLUTIONS
    GRETZ, N
    HOCKER, A
    LASSERRE, JJ
    STRAUCH, M
    [J]. NEPHRON, 1992, 61 (01): : 120 - 120
  • [8] BIOCOMPATIBILITY OF PERITONEAL-DIALYSIS SOLUTIONS
    HOLMES, CJ
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 1993, 13 (02): : 88 - 94
  • [9] SODIUM IN PERITONEAL-DIALYSIS SOLUTIONS
    BISSON, PG
    BAILEY, KM
    [J]. BRITISH MEDICAL JOURNAL, 1979, 1 (6174): : 1322 - 1323
  • [10] SODIUM IN PERITONEAL-DIALYSIS SOLUTIONS
    FORBES, AMW
    GOLDSMITH, HJ
    [J]. BRITISH MEDICAL JOURNAL, 1979, 2 (6183): : 211 - 211